urea has been researched along with Nerve Degeneration in 15 studies
pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.
Nerve Degeneration: Loss of functional activity and trophic degeneration of nerve axons and their terminal arborizations following the destruction of their cells of origin or interruption of their continuity with these cells. The pathology is characteristic of neurodegenerative diseases. Often the process of nerve degeneration is studied in research on neuroanatomical localization and correlation of the neurophysiology of neural pathways.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (60.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nguyen, TB | 1 |
| Lucero, GR | 1 |
| Chana, G | 1 |
| Hult, BJ | 1 |
| Tatro, ET | 1 |
| Masliah, E | 1 |
| Grant, I | 1 |
| Achim, CL | 1 |
| Everall, IP | 1 |
| Goyagi, T | 1 |
| Horiguchi, T | 1 |
| Nishikawa, T | 1 |
| Tobe, Y | 1 |
| Feng, JF | 2 |
| Van, KC | 2 |
| Gurkoff, GG | 2 |
| Kopriva, C | 1 |
| Olszewski, RT | 1 |
| Song, M | 2 |
| Sun, S | 1 |
| Xu, M | 1 |
| Neale, JH | 2 |
| Yuen, PW | 1 |
| Lowe, DA | 2 |
| Zhou, J | 2 |
| Lyeth, BG | 3 |
| Liu, P | 1 |
| Smith, PF | 1 |
| Appleton, I | 1 |
| Darlington, CL | 1 |
| Bilkey, DK | 1 |
| POTKONJAK, D | 1 |
| TOMIC, S | 1 |
| STERN, P | 1 |
| Zhong, C | 1 |
| Zhao, X | 1 |
| Sarva, J | 1 |
| Kozikowski, A | 1 |
| Brimijoin, WS | 1 |
| Kraśnicka, Z | 2 |
| Ohnishi, A | 1 |
| Ikeda, M | 1 |
| Olszewska, K | 1 |
| Borowicz, J | 1 |
| Javoy, F | 1 |
| Agid, Y | 1 |
| Bouvet, D | 1 |
| Glowinski, J | 1 |
| Cavanagh, JB | 3 |
| Hopewell, JW | 1 |
| Chen, FC | 2 |
| Blakemore, WF | 1 |
| Kyu, MH | 1 |
| Ridley, A | 1 |
1 review available for urea and Nerve Degeneration
| Article | Year |
|---|---|
Abnormalities of axonal transport: are they a cause of peripheral nerve disease?
Topics: Acrylamides; Animals; Axonal Transport; Diabetes Mellitus, Experimental; Humans; Muscle Contraction; | 1982 |
14 other studies available for urea and Nerve Degeneration
| Article | Year |
|---|---|
Glycogen synthase kinase-3beta (GSK-3beta) inhibitors AR-A014418 and B6B3O prevent human immunodeficiency virus-mediated neurotoxicity in primary human neurons.
Topics: AIDS Dementia Complex; Caspase 3; Caspase 7; Cells, Cultured; Enzyme Inhibitors; Glycogen Synthase K | 2009 |
Post-treatment with selective β1 adrenoceptor antagonists provides neuroprotection against transient focal ischemia in rats.
Topics: Adrenergic beta-Antagonists; Animals; Brain Infarction; Brain Ischemia; Disease Models, Animal; Male | 2010 |
Post-injury administration of NAAG peptidase inhibitor prodrug, PGI-02776, in experimental TBI.
Topics: Animals; Brain Injuries; Disease Models, Animal; Glutamate Carboxypeptidase II; Male; Mice; Mice, In | 2011 |
NAAG peptidase inhibitor reduces cellular damage in a model of TBI with secondary hypoxia.
Topics: Animals; Astrocytes; Brain Injuries; Cell Death; Cell Shape; Enzyme Inhibitors; Glutamate Carboxypep | 2012 |
Regional variations and age-related changes in nitric oxide synthase and arginase in the sub-regions of the hippocampus.
Topics: Aging; Animals; Arginase; Arginine; Dentate Gyrus; Down-Regulation; Hippocampus; Liver; Male; Memory | 2003 |
AN ATTEMPT AT CHEMOTHERAPEUTIC TREATMENT OF MOTOR CELL DAMAGE IN THE ANTERIOR HORN OF THE RAT SPINAL CORD.
Topics: Antithyroid Agents; Cresols; Cyanides; Ganglia; Ganglia, Spinal; Motor Neurons; Nerve Degeneration; | 1965 |
NAAG peptidase inhibitor reduces acute neuronal degeneration and astrocyte damage following lateral fluid percussion TBI in rats.
Topics: Animals; Astrocytes; Brain Injuries; Cell Death; Dose-Response Relationship, Drug; Glutamate Carboxy | 2005 |
Effect of serum from patients with uremic syndrome and of exogenous urea and creatinine on organotypic nerve tissue culture.
Topics: Animals; Cerebellum; Creatinine; Culture Media; Culture Techniques; Hemolytic-Uremic Syndrome; Human | 1982 |
[Experimental dying back phenomenon--morphometric evaluation of primary sensory neuron in para-bromophenylacetylurea neuropathy (author's transl)].
Topics: Animals; Axons; Male; Nerve Degeneration; Nerve Fibers, Myelinated; Neurons; Peripheral Nervous Syst | 1979 |
Effect of human uremic serum, urea and creatinine on organotypic nervous tissue culture (light and electron microscopic studies).
Topics: Animals; Cerebellum; Creatinine; Culture Media; Culture Techniques; Microscopy, Electron; Nerve Dege | 1979 |
In vivo estimation of tyrosine hydroxylation in the dopaminergic terminals of the rat neostriatum.
Topics: Animals; Corpus Striatum; Dextroamphetamine; Dihydroxyphenylalanine; Dopamine; Hydroxylation; Male; | 1974 |
Effects of 60 Co radiation on the cellular responses in degenerating dorsal columns in the rat spinal cord.
Topics: Animals; Cell Division; Cobalt Isotopes; Germ-Free Life; Male; Nerve Degeneration; Neuroglia; Phenyl | 1971 |
"Neuroaxonal dystrophy" occurring in an experimental "dying back" process in the rat.
Topics: Animals; Axons; Dimethyl Sulfoxide; Male; Microscopy, Electron; Mitosis; Nerve Degeneration; Nerve F | 1969 |
The experimental neuropathy in rats caused by p-bromophenylacetylurea.
Topics: Animals; Brain; Extremities; Female; Gliosis; Guinea Pigs; Isoniazid; Male; Motor Neurons; Nerve Deg | 1968 |